98 related articles for article (PubMed ID: 20352592)
1. [Waiting time for and length of physicianc's consultation define the patient-physician interaction: results of a prospective study in 478 patients with chronic viral hepatitis].
Niederau C; Bemba G; Kautz A; Bertram T; Schweizer R; van Thiel I
Z Gastroenterol; 2010 Apr; 48(4):455-64. PubMed ID: 20352592
[TBL] [Abstract][Full Text] [Related]
2. [Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients. Socio-economical aspects in hepatitis B].
Niederau C; Fischer C; Kautz A
Z Gastroenterol; 2007 May; 45(5):355-68. PubMed ID: 17503314
[TBL] [Abstract][Full Text] [Related]
3. [Socioeconomic characteristics, quality of life, and state of knowledge of patients with hepatitis C viral infection in Germany--socioeconomic aspects in hepatitis C].
Niederau C; Bemba G; Kautz A
Z Gastroenterol; 2006 Apr; 44(4):305-17. PubMed ID: 16625459
[TBL] [Abstract][Full Text] [Related]
4. [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Med Klin (Munich); 1993 Sep; 88(9):511-5, 562. PubMed ID: 8232088
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease.
Guptan RC; Thakur V; Malhotra V; Sarin SK
J Assoc Physicians India; 2002 May; 50(5):651-5. PubMed ID: 12186118
[TBL] [Abstract][Full Text] [Related]
6. Can physicians improve patient satisfaction with long waiting times?
Feddock CA; Hoellein AR; Griffith CH; Wilson JF; Bowerman JL; Becker NS; Caudill TS
Eval Health Prof; 2005 Mar; 28(1):40-52. PubMed ID: 15677386
[TBL] [Abstract][Full Text] [Related]
7. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].
Niederau C; Bemba G; Kautz A
Z Gastroenterol; 2008 Jan; 46(1):22-33. PubMed ID: 18188813
[TBL] [Abstract][Full Text] [Related]
8. Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study.
Guennoc X; Narbonne V; Jousse-Joulin S; Devauchelle-Pensec V; Dougados M; Daurès JP; Saraux A
J Rheumatol; 2009 Jul; 36(7):1407-13. PubMed ID: 19531755
[TBL] [Abstract][Full Text] [Related]
9. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
[TBL] [Abstract][Full Text] [Related]
11. Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study.
Hamre HJ; Witt CM; Glockmann A; Ziegler R; Willich SN; Kiene H
BMC Complement Altern Med; 2007 Apr; 7():10. PubMed ID: 17451595
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
16. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
Thomas DL; Factor SH; Kelen GD; Washington AS; Taylor E; Quinn TC
Arch Intern Med; 1993 Jul; 153(14):1705-12. PubMed ID: 8333808
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.
Crespo J; Lozano JL; de la Cruz F; Rodrigo L; Rodríguez M; San Miguel G; Artiñano E; Pons-Romero F
Am J Gastroenterol; 1994 Aug; 89(8):1147-51. PubMed ID: 8053425
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
20. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.
Kliem V; Burg M; Haller H; Suwelack B; Abendroth D; Fritsche L; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U
Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
